MedPath

Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Registration Number
NCT01621776
Lead Sponsor
University of Florida
Brief Summary

This study aims to compare the post-meal blood glucose values of two drugs in a "real-world" setting.

Detailed Description

This is a randomized, open-label trial that aims to compare the glycemic excursion following food intake following post-meal injection of Glulisine (Apidra) insulin and Lispro (Humalog) insulin in a real-world setting. Children participating in the Florida Camp for Children and Youth with Diabetes will be randomized to receive either Glulisine or Apidra to cover carbohydrates after meals. The difference in blood glucose values will be analyzed before and 2 hours after meals to see if there is a difference in post-prandial hyperglycemia between groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
107
Inclusion Criteria
  • Diagnosis of type 1 Diabetes
  • Children and Youth attending Florida Diabetes Camp in DeLand, FL
Exclusion Criteria
  • only campers participating in sessions I and II are eligible to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HumalogHumalogSubjects on this treatment arm will receive Humalog insulin for their bolus doses, with doses optimized individually to achieve glycemic targets at daily medical rounds with their cabin physicians.
ApidraApidraSubjects on this treatment arm will receive Apidra insulin for their bolus doses, with doses optimized individually to achieve glycemic targets at daily medical rounds with their cabin physicians.
NovologNovologSubjects on this treatment arm will receive Novolog insulin for their bolus doses, with doses optimized individually to achieve glycemic targets at daily medical rounds with their cabin physicians. (NOTE: This arm was only for one year of the study which was the 2012 camp session.)
Primary Outcome Measures
NameTimeMethod
The Difference Between Pre- and 120 Minute Post-prandial Blood Glucose Concentrations at Lunch.averaged over 5 days

Blood glucose concentrations were measured prior to and 90 minutes following lunch. Analysis was based on intention to treat. While missing data was imputed, it was known that this data was 'not missing at random' thus violating standard statistical assumptions with imputation. Therefore imputed data was not included in the final model.

The number of participants for analysis was based upon a convenience sample of individuals attending Florida Camp for Children and Youth with Diabetes at Camp Winona.

Secondary Outcome Measures
NameTimeMethod
Difference Between Pre- and 120 Minute Post-prandial Blood Glucose Concentrations at Breakfastaveraged over 5 days

Blood glucose concentrations were measured prior to and 120 minutes following breakfast. Analysis was based on intention to treat. While missing data was imputed, it was known that this data was 'not missing at random' thus violating standard statistical assumptions with imputation. Therefore imputed data was not included in the final model.

Difference Between Pre- and 120 Minute Post-prandial Blood Glucose Concentrations at Dinneraveraged over 5 days

Blood glucose concentrations were measured prior to and 120 minutes following dinner. Analysis was based on intention to treat. While missing data was imputed, it was known that this data was 'not missing at random' thus violating standard statistical assumptions with imputation. Therefore imputed data was not included in the final model.

Trial Locations

Locations (1)

Camp Winona

🇺🇸

DeLeon Springs, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath